We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7269:TSESuzuki Motor Corp. Analysis

Data as of 2026-06-18 - not real-time

¥1,936.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Current price of ¥1,936 sits above the 20‑day (¥1,891) and 50‑day (¥1,847) simple moving averages but remains under the 200‑day SMA (¥2,110), indicating a short‑term uptrend within a longer‑term neutral context. The MACD is bullish (line above signal, positive histogram) and the RSI at 56 suggests momentum is still intact, while volume has been trending downwards and volatility is elevated at over 42% for the past 30 days. The market sentiment index shows “Extreme Greed,” and the stock is trading near its technical resistance of ¥2,011, with support around ¥1,764.
Fundamentally, Suzuki Motor posted a 15.2% revenue growth year‑over‑year, boasts a low trailing PE of 8.5 and a price‑to‑book near 1.1, yet the discounted cash‑flow model values the company at roughly ¥1,153, implying the market price is significantly overvalued. The balance sheet reflects high leverage (debt‑to‑equity ~18) but ample cash reserves, and the firm does not pay a dividend. Analyst consensus is a “Buy” with a median target around ¥2,600, suggesting upside potential if valuation gaps narrow.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above short‑term SMAs
  • RSI in neutral‑to‑positive range
  • Proximity to technical resistance with decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Strong revenue growth and low PE relative to peers
  • Valuation gap between market price and DCF fair value
  • High leverage offset by sizable cash holdings

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Cyclical exposure in the auto sector
  • Diversified product portfolio and solid cash flow generation
  • Elevated debt‑to‑equity ratio and lack of dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin6.98%
P/E Ratio8.5
ROE13.87%
ROA6.17%
Debt/Equity18.03
P/B Ratio1.1
Op. Cash Flow¥717.5B
Free Cash Flow¥80.1B

Technical Analysis

TrendNeutral
RSI56.3
Support¥1,764.00
Resistance¥2,011.00
MA 20¥1,890.50
MA 50¥1,846.50
MA 200¥2,109.97
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73

Valuation

Fair Value¥1,152.92
Target Price¥2,544.12
Upside/Downside31.41%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.20
Volatility42.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.